240 related articles for article (PubMed ID: 18271005)
1. Hepatitis C infection and risk of malignant lymphoma.
Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M
Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis C virus infection in malignant lymphoma in Spain.
de Sanjose S; Nieters A; Goedert JJ; Domingo-Domenech E; Fernandez de Sevilla A; Bosch R; Herrera P; Domingo A; Petit J; Bosch X; Kallinowski B
Int J Cancer; 2004 Aug; 111(1):81-5. PubMed ID: 15185347
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.
Nicolosi Guidicelli S; Lopez-Guillermo A; Falcone U; Conconi A; Christinat A; Rodriguez-Abreu D; Grisanti S; Lobetti-Bodoni C; Piffaretti JC; Johnson PW; Mombelli G; Cerny A; Montserrat E; Cavalli F; Zucca E
Hematol Oncol; 2012 Sep; 30(3):137-42. PubMed ID: 22105737
[TBL] [Abstract][Full Text] [Related]
6. Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma.
Paydas S; Kilic B; Yavuz S; Disel U; Tanriverdi K; Sahin B; Burgut R
Am J Hematol; 2003 Oct; 74(2):89-93. PubMed ID: 14508793
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
Engels EA; Chatterjee N; Cerhan JR; Davis S; Cozen W; Severson RK; Whitby D; Colt JS; Hartge P
Int J Cancer; 2004 Aug; 111(1):76-80. PubMed ID: 15185346
[TBL] [Abstract][Full Text] [Related]
8. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study.
Giannoulis E; Economopoulos T; Mandraveli K; Giannoulis K; Nikolaides C; Zervou E; Papageorgiou E; Zoulas D; Tourkantonis A; Giannopoulos G; Fountzilas G;
Acta Haematol; 2004; 112(4):189-93. PubMed ID: 15564729
[TBL] [Abstract][Full Text] [Related]
11. B cell malignancy and hepatitis C virus infection.
Izumi T; Sasaki R; Tsunoda S; Akutsu M; Okamoto H; Miura Y
Leukemia; 1997 Apr; 11 Suppl 3():516-8. PubMed ID: 9209442
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet radiation exposure and risk of malignant lymphomas.
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
[TBL] [Abstract][Full Text] [Related]
13. [High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study].
Catassi C; Fabiani E; Coppa GV; Gabrielli A; Centurioni R; Leoni P; Barbato M; Viola F; Martelli M; De Renzo A; Rotoli B; Bertolani P; Federico M; Carroccio A; Iannitto E; Baldassarre M; Guarini A; Guariso G; Favaretto G; Caramaschi P; Ambrosetti A
Recenti Prog Med; 1998 Feb; 89(2):63-7. PubMed ID: 9558907
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
15. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.
de Sanjose S; Benavente Y; Vajdic CM; Engels EA; Morton LM; Bracci PM; Spinelli JJ; Zheng T; Zhang Y; Franceschi S; Talamini R; Holly EA; Grulich AE; Cerhan JR; Hartge P; Cozen W; Boffetta P; Brennan P; Maynadié M; Cocco P; Bosch R; Foretova L; Staines A; Becker N; Nieters A
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):451-8. PubMed ID: 18387498
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas.
Chindamo MC; Spector N; Segadas JA; Pimenta G; Vanderborght B; Morais JC; Milito C; Moraes Coelho HS
Oncol Rep; 2002; 9(3):657-9. PubMed ID: 11956646
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection and risk of lymphoma: immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls.
de Sanjosé S; Bosch R; Schouten T; Verkuijlen S; Nieters A; Foretova L; Maynadié M; Cocco PL; Staines A; Becker N; Brennan P; Benavente Y; Boffetta P; Meijer CJ; Middeldorp JM
Int J Cancer; 2007 Oct; 121(8):1806-12. PubMed ID: 17557295
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
Mizorogi F; Hiramoto J; Nozato A; Takekuma Y; Nagayama K; Tanaka T; Takagi K
Intern Med; 2000 Feb; 39(2):112-7. PubMed ID: 10732826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
